CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Adrian Minson; Nada Hamad; Chan Y. Cheah; Constantine S. Tam; Piers Blombery; David Westerman; David Ritchie; Huw Morgan; Nicholas Holzwart; Stephen Lade; Mary Ann Anderson; Amit Khot; John F. Seymour; Molly Robertson; Imogen Caldwell; Georgina L. Ryland; Javad Saghebi; Zahra Sabahi; Jing Xie; Rachel Koldej; Michael Dickinson

doi:10.1182/blood.2023021306

Related publications

Article2024

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Marco Herling, Claire Dearden, Francesco Zaja, Dima El‐Sharkawi, Wei Ding, Mar Bellido, Amit Khot, Lidwine W. Tick, Eric D. Jacobsen, Toby A. Eyre, Damien Roos‐Weil, Tapan Kadia, Elisa Lucchini, Natali Pflug, Matthew S. Davids, Germán Peña, Nabanita Mukherjee, Mohamed Badawi, Tamas Vizkelety, Philipp B. Staber

Article2021

T-Cell Replete Allogeneic Stem Cell Transplant Is an Effective Treatment Option for Patients with TP53 mutated Mantle Cell Lymphoma

Edward R. Scheffer Cliff, Thomas E. Lew, Piers Blombery, Michael Dickinson, Constantine S. Tam, John F. Seymour, Ashish Bajel, David Ritchie, Amit Khot

Article2019

Longitudinal T Cell Immunoprofiling of Patients with Relapsed and/or Refractory Myeloma Who Receive Daratumumab Monotherapy: A Subanalysis of a Phase 2 Study (the REBUILD Study)

Elisavet Vlachonikola, Anna Vardi, Eftathios Kastritis, Evdoxia Hatjiharissi, Eirini Katodritou, Alexandra Siorenta, Electra Sofou, Konstantia Kotta, Maria Karipidou, Maria Gavriatopoulou, Sosana Delimpasi, Argiris Symeonidis, Κώστας Σταματόπουλος, Meletios A Dimopoulos, Evangelos Terpos, Anastasia Chatzidimitriou

Letter2016

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström’s macroglobulinemia

Maria Gavriatopoulou, Efstathios Kastritis, Marie‐Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Μαρία Ρούσσου, Despina Fotiou, Magdalini Migkou, Maria Mpakiri, Anna Tasidou, Evangelos Terpos, Meletios A Dimopoulos

Article2024

CAR-T Cells for the Treatment of Central Nervous System Tumours: Known and Emerging Neurotoxicities

Leonardo Palazzo, Valentina Pieri, Giulia Berzero, Massimo Filippi